Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI108782

Hormonal Control of Adrenocortical Cell Proliferation: DESENSITIZATION TO ACTH AND INTERACTION BETWEEN ACTH AND FIBROBLAST GROWTH FACTOR IN BOVINE ADRENOCORTICAL CELL CULTURES

Peter J. Hornsby and Gordon N. Gill

Department of Medicine, University of California, San Diego, La Jolla, California 92093

Division of Endocrinology, University of California, San Diego, La Jolla, California 92093

School of Medicine, La Jolla, California 92093

Find articles by Hornsby, P. in: PubMed | Google Scholar

Department of Medicine, University of California, San Diego, La Jolla, California 92093

Division of Endocrinology, University of California, San Diego, La Jolla, California 92093

School of Medicine, La Jolla, California 92093

Find articles by Gill, G. in: PubMed | Google Scholar

Published August 1, 1977 - More info

Published in Volume 60, Issue 2 on August 1, 1977
J Clin Invest. 1977;60(2):342–352. https://doi.org/10.1172/JCI108782.
© 1977 The American Society for Clinical Investigation
Published August 1, 1977 - Version history
View PDF
Abstract

A primary bovine adrenocortical cell culture system responsive to physiological concentrations of ACTH has been established. When added to cultures, ACTH inhibited DNA synthesis and cell division over the same concentration range required for stimulation of fluorogenic steroid production (0.01-10 nM). With chronic exposure to ACTH, cells became desensitized to the growth inhibitory effects of ACTH. Though cell growth was initially completely inhibited by ACTH, cells ultimately began to grow in its continued presence. The lag time to initiation of cell growth, the rate of growth, and the final density achieved depended on the ACTH concentration. Desensitization to ACTH1-39 was not induced by monobutyryl cyclic AMP nor by ACTH11-24. Specificity of desensitization was apparent because cells which had become desensitized to ACTH1-39 remained fully responsive to monobutyryl cyclic AMP, prostaglandin E1, and cholera toxin. Though the effects of ACTH on cell growth were readily reversible upon hormone removal, the desensitized response to readdition of ACTH persisted for at least 8 h.

Fibroblast growth factor (FGF) stimulated both the growth rate and saturation density achieved. FGF did not alter the growth inhibitory effects of ACTH nor the reduced growth rate observed in desensitized cells maintained in ACTH. However, FGF greatly increased the saturation density achieved by cultures maintained with ACTH.

Through the process of desensitization, adrenocortical cells are able to grow in the presence of high concentrations of ACTH and to respond to the effects of a growth factor by increasing the cell density achieved. This pattern of response may be a general one for growth control under the combined effects of antimitotic and mitotic factors.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 342
page 342
icon of scanned page 343
page 343
icon of scanned page 344
page 344
icon of scanned page 345
page 345
icon of scanned page 346
page 346
icon of scanned page 347
page 347
icon of scanned page 348
page 348
icon of scanned page 349
page 349
icon of scanned page 350
page 350
icon of scanned page 351
page 351
icon of scanned page 352
page 352
Version history
  • Version 1 (August 1, 1977): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts